Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04707781

Database for Interstitial Lung Disease

The purpose of this study is to establish a clinical database for patients bearing at risk for ILD (Interstitial Lung Disease) and to set up a prospective ILD Screening program for these patients.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Diseases, Interstitial Lung Diseases Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: ≥ 18 years
  • patients with a known systemic disease bearing a risk for ILD
  • signed informed consent (for prospective part)

Exclusion criteria

  • Age < 18 years
  • comorbidities severely limiting life-expectancy (e.g. severe cardiovascular conditions, malignant disease)

Treatment and study plan

Chest CT

Diagnostic Test

assessment of interstitial lung disease using chest CT

Primary outcomes

  1. DLCO%pred (carbon monoxide diffusing capacity) at time of ILD diagnosis

    Time frame: 5 years

    The investigators aim to assess DLCO% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the DLCO%pred at time of ILD diagnosis

Secondary outcomes

  1. FVC%pred (Forced vital capacity) at time of ILD diagnosis

    Time frame: 5 years

    The investigators aim to assess FVC% pred at time of ILD diagnosis in patients undergoing a ILD Screening algorithm and compare to the retrospective patient cohort with diagnosed ILD and the FVC%pred at time of ILD diagnosis

Study contacts

Contact information is provided by the study sponsor or research team.

Gabor Kovacs, MD

CONTACT

[email protected]

+43-316-385 ext. 12183

Sponsors and collaborators

Lead sponsor

Medical University of Graz

Other

Collaborators

  • Boehringer Ingelheim

Registry information

Official study title

Clinical Database for the Early Recognition of Pulmonary Parenchymal Involvement in Patients With Systemic Diseases Bearing a Risk for Interstitial Lung Disease

Important dates

Study start
2021
Primary completion
2029
Study completion
2029
First posted
Jan 13, 2021
Registry last updated
Jan 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.